{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:55:25Z","timestamp":1785477325995,"version":"3.56.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Hebei Natural Science Foundation","doi-asserted-by":"crossref","award":["H2022104021"],"award-info":[{"award-number":["H2022104021"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02522-6","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T01:37:52Z","timestamp":1744681072000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical spectrum, genetics and management insights of PAX2-related disorder in nine children"],"prefix":"10.1186","volume":"30","author":[{"given":"Jie","family":"Min","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaona","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"2522_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.semcdb.2015.08.014","volume":"44","author":"VR Paixao-Cortes","year":"2015","unstructured":"Paixao-Cortes VR, Salzano FM, Bortolini MC. Origins and evolvability of the PAX family. Semin Cell Dev Biol. 2015;44:64\u201374. https:\/\/doi.org\/10.1016\/j.semcdb.2015.08.014.","journal-title":"Semin Cell Dev Biol"},{"key":"2522_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku1055","author":"GR Brown","year":"2015","unstructured":"Brown GR, Hem V, Katz KS, et al. Gene: a gene-centered information resource at NCBI. Nucleic Acids Res. 2015. https:\/\/doi.org\/10.1093\/nar\/gku1055.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"2522_CR3","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00467-011-2053-0","volume":"27","author":"LA Harshman","year":"2012","unstructured":"Harshman LA, Brophy PD. PAX2 in human kidney malformations and disease. Pediatr Nephrol. 2012;27(8):1265\u201375. https:\/\/doi.org\/10.1007\/s00467-011-2053-0.","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"2522_CR4","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1242\/dev.127.5.1017","volume":"127","author":"PL Pfeffer","year":"2000","unstructured":"Pfeffer PL, Bouchard M, Busslinger M. Pax2 and homeodomain proteins cooperatively regulate a 435 bp enhancer of the mouse Pax5 gene at the midbrain\u2013hindbrain boundary. Development. 2000;127(5):1017\u201328. https:\/\/doi.org\/10.1242\/dev.127.5.1017.","journal-title":"Development"},{"issue":"4","key":"2522_CR5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.gde.2005.05.001","volume":"15","author":"Z Kozmik","year":"2005","unstructured":"Kozmik Z. Pax genes in eye development and evolution. Curr Opin Genet Dev. 2005;15(4):430\u20138. https:\/\/doi.org\/10.1016\/j.gde.2005.05.001.","journal-title":"Curr Opin Genet Dev"},{"key":"2522_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ydbio.2024.09.009","volume":"517","author":"W Roberson","year":"2025","unstructured":"Roberson W, Holland JN, Riley BB. Pax2a, Pax5 and Cdh1-beta-catenin, but not Wnt, protect sensory hair cells from destabilizing effects of fgf signaling on cell adhesion. Dev Biol. 2025;517:157\u201367. https:\/\/doi.org\/10.1016\/j.ydbio.2024.09.009.","journal-title":"Dev Biol"},{"issue":"1","key":"2522_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/hmg\/9.1.1","volume":"9","author":"S Porteous","year":"2000","unstructured":"Porteous S, Torban E, Cho NP, et al. Primary renal hypoplasia in humans and mice with PAX2 mutations: evidence of increased apoptosis in fetal kidneys of Pax2(1Neu) +\/- mutant mice. Hum Mol Genet. 2000;9(1):1\u201311. https:\/\/doi.org\/10.1093\/hmg\/9.1.1.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"2522_CR8","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1093\/hmg\/4.11.2183","volume":"4","author":"P Sanyanusin","year":"1995","unstructured":"Sanyanusin P, Mcnoe LA, Sullivan MJ, et al. Mutation of PAX2 in two siblings with renal-coloboma syndrome. Hum Mol Genet. 1995;4(11):2183\u20134. https:\/\/doi.org\/10.1093\/hmg\/4.11.2183.","journal-title":"Hum Mol Genet"},{"key":"2522_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612737","author":"C Muntean","year":"2023","unstructured":"Muntean C, Chirtes C, Baczoni B, et al. PAX2 gene mutation in pediatric renal disorders-a narrative review. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241612737.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2522_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12920-021-01102-x","volume":"14","author":"X Yang","year":"2021","unstructured":"Yang X, Li Y, Fang Y, et al. Phenotypic spectrum and genetics of PAX2-related disorder in the Chinese cohort. BMC Med Genomics. 2021;14(1):250. https:\/\/doi.org\/10.1186\/s12920-021-01102-x.","journal-title":"BMC Med Genomics"},{"issue":"6","key":"2522_CR11","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s10038-020-0741-y","volume":"65","author":"R Rossanti","year":"2020","unstructured":"Rossanti R, Morisada N, Nozu K, et al. Clinical and genetic variability of PAX2-related disorder in the Japanese population. J Hum Genet. 2020;65(6):541\u20139. https:\/\/doi.org\/10.1038\/s10038-020-0741-y.","journal-title":"J Hum Genet"},{"issue":"6","key":"2522_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.701","volume":"7","author":"H Deng","year":"2019","unstructured":"Deng H, Zhang Y, Xiao H, et al. Diverse phenotypes in children with PAX2-related disorder. Mol Genet Genomic Med. 2019;7(6): e701. https:\/\/doi.org\/10.1002\/mgg3.701.","journal-title":"Mol Genet Genomic Med"},{"issue":"2","key":"2522_CR13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/MOP.0b013e32834fdbd4","volume":"24","author":"S Weber","year":"2012","unstructured":"Weber S. Novel genetic aspects of congenital anomalies of kidney and urinary tract. Curr Opin Pediatr. 2012;24(2):212\u20138. https:\/\/doi.org\/10.1097\/MOP.0b013e32834fdbd4.","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"2522_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/ndt\/gfab218","volume":"37","author":"N Knoers","year":"2022","unstructured":"Knoers N, Antignac C, Bergmann C, et al. Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice. Nephrol Dial Transplant. 2022;37(2):239\u201354. https:\/\/doi.org\/10.1093\/ndt\/gfab218.","journal-title":"Nephrol Dial Transplant"},{"key":"2522_CR15","unstructured":"Li H, Capital Institute of Pediatrics C S G O N C O T P G, Development Of C. Growth standardized values and curves based on weight, length\/height and head circumference for Chinese children under 7 years of age]. Zhonghua Er Ke Za Zhi, 2009, 47(3): 173\u20138."},{"key":"2522_CR16","unstructured":"Coordinating Study Group of Nine Cities on Physical G, Development Of C, Capital Institute Of P A national survey on growth of children under 7 years of age in nine cities of China, 2005. Zhonghua Er Ke Za Zhi. 2007, 45(8): 609\u201314. DOI."},{"issue":"5","key":"2522_CR17","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00467-021-05303-5","volume":"37","author":"L Obrycki","year":"2022","unstructured":"Obrycki L, Sarnecki J, Lichosik M, et al. Kidney length normative values in children aged 0\u201319 years - a multicenter study. Pediatr Nephrol. 2022;37(5):1075\u201385. https:\/\/doi.org\/10.1007\/s00467-021-05303-5.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"2522_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jpeds.2012.06.008","volume":"162","author":"DG Noone","year":"2013","unstructured":"Noone DG, Marks SD. Hyperuricemia is associated with hypertension, obesity, and albuminuria in children with chronic kidney disease. J Pediatr. 2013;162(1):128\u201332. https:\/\/doi.org\/10.1016\/j.jpeds.2012.06.008.","journal-title":"J Pediatr"},{"issue":"6","key":"2522_CR19","doi-asserted-by":"publisher","first-page":"422","DOI":"10.7326\/M17-2640","volume":"168","author":"M Ketteler","year":"2018","unstructured":"Ketteler M, Block GA, Evenepoel P, et al. Diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder: synopsis of the kidney disease: improving global outcomes 2017 clinical practice guideline update. Ann Intern Med. 2018;168(6):422\u201330. https:\/\/doi.org\/10.7326\/M17-2640.","journal-title":"Ann Intern Med"},{"issue":"5","key":"2522_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the american college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"issue":"11","key":"2522_CR21","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/humu.23626","volume":"39","author":"AN Abou Tayoun","year":"2018","unstructured":"Abou Tayoun AN, Pesaran T, Distefano MT, et al. Recommendations for interpreting the loss of function PVS1 ACMG\/AMP variant criterion. Hum Mutat. 2018;39(11):1517\u201324. https:\/\/doi.org\/10.1002\/humu.23626.","journal-title":"Hum Mutat"},{"issue":"12","key":"2522_CR22","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/gim.2018.42","volume":"20","author":"LG Biesecker","year":"2018","unstructured":"Biesecker LG, Harrison SM. Clingen sequence variant interpretation working G The ACMG\/AMP reputable source criteria for the interpretation of sequence variants. Genet Med. 2018;20(12):1687\u20138. https:\/\/doi.org\/10.1038\/gim.2018.42.","journal-title":"Genet Med"},{"issue":"11","key":"2522_CR23","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1002\/humu.23642","volume":"39","author":"R Ghosh","year":"2018","unstructured":"Ghosh R, Harrison SM, Rehm HL, et al. Updated recommendation for the benign stand-alone ACMG\/AMP criterion. Hum Mutat. 2018;39(11):1525\u201330. https:\/\/doi.org\/10.1002\/humu.23642.","journal-title":"Hum Mutat"},{"issue":"10","key":"2522_CR24","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","volume":"65","author":"X Chen","year":"2013","unstructured":"Chen X, Zaro JL, Shen WC. Fusion protein linkers: property, design and functionality. Adv Drug Deliv Rev. 2013;65(10):1357\u201369. https:\/\/doi.org\/10.1016\/j.addr.2012.09.039.","journal-title":"Adv Drug Deliv Rev"},{"key":"2522_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.799562","volume":"13","author":"HY Xiong","year":"2022","unstructured":"Xiong HY, Shi YQ, Zhong C, et al. Detection of de novo PAX2 variants and phenotypes in chinese population: a single-center study. Front Genet. 2022;13: 799562. https:\/\/doi.org\/10.3389\/fgene.2022.799562.","journal-title":"Front Genet"},{"issue":"1","key":"2522_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2024.104313","volume":"47","author":"C Yavas","year":"2025","unstructured":"Yavas C, Dogan M, Ozgor B, et al. Novel biallelic nonsense mutation in IGHMBP2 gene linked to neuropathy (CMT2S): a comprehensive clinical, genetic and bioinformatic analysis of a Turkish patient with literature review. Brain Dev. 2025;47(1): 104313. https:\/\/doi.org\/10.1016\/j.braindev.2024.104313.","journal-title":"Brain Dev"},{"key":"2522_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/cge.14708","author":"C Yavas","year":"2025","unstructured":"Yavas C, Arvas YE, Dogan M, et al. Revealing molecular diagnosis with whole exome sequencing in patients with inherited retinal disorders. Clin Genet. 2025. https:\/\/doi.org\/10.1111\/cge.14708.","journal-title":"Clin Genet"},{"issue":"5","key":"2522_CR28","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s13258-024-01502-0","volume":"46","author":"C Yavas","year":"2024","unstructured":"Yavas C, Dogan M, Eroz R, et al. A rare TNNT1 gene variant causing creatine kinase elevation in nemaline myopathy: c.271_273del (p.Lys91del). Genes Genomics. 2024;46(5):613\u201320. https:\/\/doi.org\/10.1007\/s13258-024-01502-0.","journal-title":"Genes Genomics"},{"issue":"1","key":"2522_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000533915","volume":"15","author":"C Yavas","year":"2024","unstructured":"Yavas C, Ozgenturk NO, Dogan M, et al. A Deeper Insight into COL4A3, COL4A4, and COL4A5 variants and genotype-phenotype correlation of a turkish cohort with alport syndrome. Mol Syndromol. 2024;15(1):1\u201313. https:\/\/doi.org\/10.1159\/000533915.","journal-title":"Mol Syndromol"},{"issue":"8","key":"2522_CR30","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.34067\/KID.0000812022","volume":"3","author":"C Nagano","year":"2022","unstructured":"Nagano C, Hara S, Yoshikawa N, et al. Clinical pathological, and genetic characteristics in patients with focal segmental glomerulosclerosis. Kidney. 2022;3(8):1384\u201393. https:\/\/doi.org\/10.34067\/KID.0000812022.","journal-title":"Kidney"},{"issue":"11","key":"2522_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142843","volume":"10","author":"T Okumura","year":"2015","unstructured":"Okumura T, Furuichi K, Higashide T, et al. Association of PAX2 and other gene mutations with the clinical manifestations of renal coloboma syndrome. PLoS ONE. 2015;10(11): e0142843. https:\/\/doi.org\/10.1371\/journal.pone.0142843.","journal-title":"PLoS ONE"},{"issue":"5","key":"2522_CR32","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ajhg.2017.09.018","volume":"101","author":"S Sanna-Cherchi","year":"2017","unstructured":"Sanna-Cherchi S, Khan K, Westland R, et al. Exome-wide association study identifies GREB1L mutations in congenital kidney malformations. Am J Hum Genet. 2017;101(5):789\u2013802. https:\/\/doi.org\/10.1016\/j.ajhg.2017.09.018.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"2522_CR33","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.kint.2018.10.031","volume":"95","author":"DM Connaughton","year":"2019","unstructured":"Connaughton DM, Kennedy C, Shril S, et al. Monogenic causes of chronic kidney disease in adults. Kidney Int. 2019;95(4):914\u201328. https:\/\/doi.org\/10.1016\/j.kint.2018.10.031.","journal-title":"Kidney Int"},{"issue":"5","key":"2522_CR34","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1007\/s40620-020-00898-8","volume":"34","author":"T Vaisitti","year":"2021","unstructured":"Vaisitti T, Sorbini M, Callegari M, et al. Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experience. J Nephrol. 2021;34(5):1767\u201381. https:\/\/doi.org\/10.1007\/s40620-020-00898-8.","journal-title":"J Nephrol"},{"issue":"6","key":"2522_CR35","doi-asserted-by":"publisher","first-page":"497","DOI":"10.5414\/cnp72497","volume":"72","author":"T Miyazawa","year":"2009","unstructured":"Miyazawa T, Nakano M, Takemura Y, et al. A case of renal-coloboma syndrome associated with mental developmental delay exhibiting a novel PAX2 gene mutation. Clin Nephrol. 2009;72(6):497\u2013500. https:\/\/doi.org\/10.5414\/cnp72497.","journal-title":"Clin Nephrol"},{"issue":"3","key":"2522_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1017\/s0012162204000271","volume":"46","author":"A Garcia-Cazorla","year":"2004","unstructured":"Garcia-Cazorla A, Sans A, Baquero M, et al. White matter alterations associated with chromosomal disorders. Dev Med Child Neurol. 2004;46(3):148\u201353. https:\/\/doi.org\/10.1017\/s0012162204000271.","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"2522_CR37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41398-019-0440-7","volume":"9","author":"M Drakesmith","year":"2019","unstructured":"Drakesmith M, Parker GD, Smith J, et al. Genetic risk for schizophrenia and developmental delay is associated with shape and microstructure of midline white-matter structures. Transl Psychiatry. 2019;9(1):102. https:\/\/doi.org\/10.1038\/s41398-019-0440-7.","journal-title":"Transl Psychiatry"},{"issue":"10","key":"2522_CR38","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/s00467-008-1108-3","volume":"24","author":"GH Neild","year":"2009","unstructured":"Neild GH. What do we know about chronic renal failure in young adults? I primary renal disease. Pediatr Nephrol. 2009;24(10):1913\u20139. https:\/\/doi.org\/10.1007\/s00467-008-1108-3.","journal-title":"Pediatr Nephrol"},{"key":"2522_CR39","doi-asserted-by":"crossref","unstructured":"Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet. 349(9069): 1857\u201363. DOI.","DOI":"10.1016\/S0140-6736(96)11445-8"},{"issue":"15","key":"2522_CR40","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1056\/NEJM199604113341502","volume":"334","author":"G Maschio","year":"1996","unstructured":"Maschio G, Alberti D, Janin G, et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency the angiotensin-converting-enzyme inhibition in progressive renal insufficiency study group. N Engl J Med. 1996;334(15):939\u201345. https:\/\/doi.org\/10.1056\/NEJM199604113341502.","journal-title":"N Engl J Med."},{"issue":"7","key":"2522_CR41","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s00467-020-04788-w","volume":"36","author":"EY Chan","year":"2021","unstructured":"Chan EY, Ma AL, Tullus K. When should we start and stop ACEi\/ARB in paediatric chronic kidney disease? Pediatr Nephrol. 2021;36(7):1751\u201364. https:\/\/doi.org\/10.1007\/s00467-020-04788-w.","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"2522_CR42","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.cub.2006.02.072","volume":"16","author":"KD Wagner","year":"2006","unstructured":"Wagner KD, Wagner N, Guo JK, et al. An inducible mouse model for PAX2-dependent glomerular disease: insights into a complex pathogenesis. Curr Biol. 2006;16(8):793\u2013800. https:\/\/doi.org\/10.1016\/j.cub.2006.02.072.","journal-title":"Curr Biol"},{"issue":"2","key":"2522_CR43","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1177\/1470320314543910","volume":"16","author":"J Zhang","year":"2015","unstructured":"Zhang J, Yanez D, Floege A, et al. ACE-inhibition increases podocyte number in experimental glomerular disease independent of proliferation. J Renin Angiotensin Aldosterone Syst. 2015;16(2):234\u201348. https:\/\/doi.org\/10.1177\/1470320314543910.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"1","key":"2522_CR44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00467-015-3184-5","volume":"31","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Wang F, Ding J, et al. Long-term treatment by ACE inhibitors and angiotensin receptor blockers in children with Alport syndrome. Pediatr Nephrol. 2016;31(1):67\u201372. https:\/\/doi.org\/10.1007\/s00467-015-3184-5.","journal-title":"Pediatr Nephrol"},{"issue":"17","key":"2522_CR45","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","volume":"361","author":"E Wuhl","year":"2009","unstructured":"Group ET, Wuhl E, Trivelli A, et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med. 2009;361(17):1639\u201350. https:\/\/doi.org\/10.1056\/NEJMoa0902066.","journal-title":"N Engl J Med"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02522-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02522-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02522-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T14:52:14Z","timestamp":1744728734000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02522-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2522"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02522-6","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval of this study ([2024] -E-116-R) was obtained from the Ethical Committee of Beijing Children\u2019s Hospital, Capital Medical University. The Institutional Review Board has approved the study protocol involving child participants, and the clinical investigation was conducted according to the principles expressed in the Declaration of Helsinki. In our study, all parents of children who received ACEIs treatment provided written informed consent prior to the initiation of therapy. In clinical practice, physicians thoroughly explained to the parents the rationale for using ACEIs, including potential risks such as hypotension and hyperkalemia, as well as possible benefits like slowing the progression of renal dysfunction and reducing proteinuria, ensuring that parents made an informed decision after comprehensive understanding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"276"}}